nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoxetate—ABCC3—Methotrexate—multiple sclerosis	0.163	0.239	CbGbCtD
Gadoxetate—SLCO1B3—Methotrexate—multiple sclerosis	0.144	0.212	CbGbCtD
Gadoxetate—ABCC4—Methotrexate—multiple sclerosis	0.124	0.182	CbGbCtD
Gadoxetate—ABCC2—Dexamethasone—multiple sclerosis	0.092	0.135	CbGbCtD
Gadoxetate—SLCO1B1—Methotrexate—multiple sclerosis	0.0841	0.123	CbGbCtD
Gadoxetate—ABCC2—Methotrexate—multiple sclerosis	0.0739	0.108	CbGbCtD
Gadoxetate—Gadofosveset trisodium—ALB—multiple sclerosis	0.00444	1	CrCbGaD
Gadoxetate—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00175	0.0523	CbGpPWpGaD
Gadoxetate—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00175	0.0523	CbGpPWpGaD
Gadoxetate—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00138	0.0414	CbGpPWpGaD
Gadoxetate—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00138	0.0414	CbGpPWpGaD
Gadoxetate—ABCC3—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.00136	0.0406	CbGpPWpGaD
Gadoxetate—ABCC4—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.00127	0.0381	CbGpPWpGaD
Gadoxetate—ABCC2—Irinotecan Pathway—BCHE—multiple sclerosis	0.00123	0.0367	CbGpPWpGaD
Gadoxetate—SLCO1B1—Irinotecan Pathway—BCHE—multiple sclerosis	0.00115	0.0345	CbGpPWpGaD
Gadoxetate—ABCC3—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000995	0.0298	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transport of organic anions—ALB—multiple sclerosis	0.000979	0.0293	CbGpPWpGaD
Gadoxetate—ABCC4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000935	0.028	CbGpPWpGaD
Gadoxetate—ABCC4—Ectoderm Differentiation—AHI1—multiple sclerosis	0.000932	0.0279	CbGpPWpGaD
Gadoxetate—ABCC2—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000789	0.0236	CbGpPWpGaD
Gadoxetate—SLCO1B1—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000741	0.0222	CbGpPWpGaD
Gadoxetate—SLCO1B3—Recycling of bile acids and salts—ALB—multiple sclerosis	0.000725	0.0217	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—PLEK—multiple sclerosis	0.000675	0.0202	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transport of organic anions—ALB—multiple sclerosis	0.000658	0.0197	CbGpPWpGaD
Gadoxetate—ABCC3—Recycling of bile acids and salts—ALB—multiple sclerosis	0.000655	0.0196	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—PLEK—multiple sclerosis	0.000643	0.0192	CbGpPWpGaD
Gadoxetate—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000571	0.0171	CbGpPWpGaD
Gadoxetate—SLCO1B1—Recycling of bile acids and salts—ALB—multiple sclerosis	0.000487	0.0146	CbGpPWpGaD
Gadoxetate—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000453	0.0136	CbGpPWpGaD
Gadoxetate—SLCO1B3—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000409	0.0122	CbGpPWpGaD
Gadoxetate—SLCO1B3—Bile acid and bile salt metabolism—ALB—multiple sclerosis	0.000379	0.0113	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—ALB—multiple sclerosis	0.000363	0.0109	CbGpPWpGaD
Gadoxetate—ABCC3—Bile acid and bile salt metabolism—ALB—multiple sclerosis	0.000342	0.0102	CbGpPWpGaD
Gadoxetate—Syncope—Triamcinolone—multiple sclerosis	0.00034	0.00121	CcSEcCtD
Gadoxetate—Vertigo—Methylprednisolone—multiple sclerosis	0.00034	0.00121	CcSEcCtD
Gadoxetate—Syncope—Methylprednisolone—multiple sclerosis	0.000339	0.00121	CcSEcCtD
Gadoxetate—Connective tissue disorder—Prednisone—multiple sclerosis	0.000338	0.0012	CcSEcCtD
Gadoxetate—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000338	0.0012	CcSEcCtD
Gadoxetate—Oedema—Prednisolone—multiple sclerosis	0.000336	0.0012	CcSEcCtD
Gadoxetate—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000336	0.0012	CcSEcCtD
Gadoxetate—Dizziness—Azathioprine—multiple sclerosis	0.000335	0.00119	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000335	0.00119	CcSEcCtD
Gadoxetate—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000333	0.00119	CcSEcCtD
Gadoxetate—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000332	0.00118	CcSEcCtD
Gadoxetate—Shock—Prednisolone—multiple sclerosis	0.000331	0.00118	CcSEcCtD
Gadoxetate—Cough—Triamcinolone—multiple sclerosis	0.000331	0.00118	CcSEcCtD
Gadoxetate—Convulsion—Triamcinolone—multiple sclerosis	0.000328	0.00117	CcSEcCtD
Gadoxetate—Tachycardia—Prednisolone—multiple sclerosis	0.000328	0.00117	CcSEcCtD
Gadoxetate—Convulsion—Methylprednisolone—multiple sclerosis	0.000328	0.00117	CcSEcCtD
Gadoxetate—Urticaria—Mitoxantrone—multiple sclerosis	0.000326	0.00116	CcSEcCtD
Gadoxetate—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000325	0.00116	CcSEcCtD
Gadoxetate—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000324	0.00115	CcSEcCtD
Gadoxetate—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000324	0.00115	CcSEcCtD
Gadoxetate—Vomiting—Azathioprine—multiple sclerosis	0.000323	0.00115	CcSEcCtD
Gadoxetate—Anxiety—Methylprednisolone—multiple sclerosis	0.000321	0.00114	CcSEcCtD
Gadoxetate—Rash—Azathioprine—multiple sclerosis	0.00032	0.00114	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.00032	0.00114	CcSEcCtD
Gadoxetate—Dermatitis—Azathioprine—multiple sclerosis	0.00032	0.00114	CcSEcCtD
Gadoxetate—Flushing—Prednisone—multiple sclerosis	0.000319	0.00114	CcSEcCtD
Gadoxetate—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000319	0.00114	CcSEcCtD
Gadoxetate—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000319	0.00114	CcSEcCtD
Gadoxetate—Discomfort—Triamcinolone—multiple sclerosis	0.000319	0.00114	CcSEcCtD
Gadoxetate—Discomfort—Methylprednisolone—multiple sclerosis	0.000318	0.00113	CcSEcCtD
Gadoxetate—Headache—Azathioprine—multiple sclerosis	0.000318	0.00113	CcSEcCtD
Gadoxetate—Dry mouth—Triamcinolone—multiple sclerosis	0.000316	0.00112	CcSEcCtD
Gadoxetate—Renal failure—Methotrexate—multiple sclerosis	0.000315	0.00112	CcSEcCtD
Gadoxetate—Angiopathy—Prednisone—multiple sclerosis	0.000312	0.00111	CcSEcCtD
Gadoxetate—Conjunctivitis—Methotrexate—multiple sclerosis	0.000311	0.00111	CcSEcCtD
Gadoxetate—Immune system disorder—Prednisone—multiple sclerosis	0.000311	0.00111	CcSEcCtD
Gadoxetate—Malaise—Dexamethasone—multiple sclerosis	0.00031	0.0011	CcSEcCtD
Gadoxetate—Malaise—Betamethasone—multiple sclerosis	0.00031	0.0011	CcSEcCtD
Gadoxetate—SLCO1B3—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.00031	0.00928	CbGpPWpGaD
Gadoxetate—Oedema—Triamcinolone—multiple sclerosis	0.000309	0.0011	CcSEcCtD
Gadoxetate—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000309	0.0011	CcSEcCtD
Gadoxetate—Vertigo—Dexamethasone—multiple sclerosis	0.000309	0.0011	CcSEcCtD
Gadoxetate—Vertigo—Betamethasone—multiple sclerosis	0.000309	0.0011	CcSEcCtD
Gadoxetate—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000309	0.0011	CcSEcCtD
Gadoxetate—Syncope—Betamethasone—multiple sclerosis	0.000308	0.0011	CcSEcCtD
Gadoxetate—Syncope—Dexamethasone—multiple sclerosis	0.000308	0.0011	CcSEcCtD
Gadoxetate—Arrhythmia—Prednisone—multiple sclerosis	0.000307	0.00109	CcSEcCtD
Gadoxetate—Infection—Triamcinolone—multiple sclerosis	0.000307	0.00109	CcSEcCtD
Gadoxetate—Infection—Methylprednisolone—multiple sclerosis	0.000307	0.00109	CcSEcCtD
Gadoxetate—Shock—Triamcinolone—multiple sclerosis	0.000304	0.00108	CcSEcCtD
Gadoxetate—Shock—Methylprednisolone—multiple sclerosis	0.000304	0.00108	CcSEcCtD
Gadoxetate—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000303	0.00108	CcSEcCtD
Gadoxetate—Loss of consciousness—Betamethasone—multiple sclerosis	0.000302	0.00108	CcSEcCtD
Gadoxetate—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000302	0.00108	CcSEcCtD
Gadoxetate—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000302	0.00108	CcSEcCtD
Gadoxetate—Paraesthesia—Prednisolone—multiple sclerosis	0.000302	0.00108	CcSEcCtD
Gadoxetate—Tachycardia—Triamcinolone—multiple sclerosis	0.000302	0.00107	CcSEcCtD
Gadoxetate—Nausea—Azathioprine—multiple sclerosis	0.000301	0.00107	CcSEcCtD
Gadoxetate—Tachycardia—Methylprednisolone—multiple sclerosis	0.000301	0.00107	CcSEcCtD
Gadoxetate—Skin disorder—Methylprednisolone—multiple sclerosis	0.0003	0.00107	CcSEcCtD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	0.000299	0.00896	CbGpPWpGaD
Gadoxetate—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000299	0.00106	CcSEcCtD
Gadoxetate—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000298	0.00106	CcSEcCtD
Gadoxetate—Convulsion—Dexamethasone—multiple sclerosis	0.000298	0.00106	CcSEcCtD
Gadoxetate—Convulsion—Betamethasone—multiple sclerosis	0.000298	0.00106	CcSEcCtD
Gadoxetate—Asthenia—Mitoxantrone—multiple sclerosis	0.000294	0.00105	CcSEcCtD
Gadoxetate—Anxiety—Dexamethasone—multiple sclerosis	0.000292	0.00104	CcSEcCtD
Gadoxetate—Anxiety—Betamethasone—multiple sclerosis	0.000292	0.00104	CcSEcCtD
Gadoxetate—Discomfort—Betamethasone—multiple sclerosis	0.000289	0.00103	CcSEcCtD
Gadoxetate—Discomfort—Dexamethasone—multiple sclerosis	0.000289	0.00103	CcSEcCtD
Gadoxetate—Hypotension—Methylprednisolone—multiple sclerosis	0.000288	0.00103	CcSEcCtD
Gadoxetate—Vision blurred—Prednisone—multiple sclerosis	0.000282	0.001	CcSEcCtD
Gadoxetate—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000281	0.000999	CcSEcCtD
Gadoxetate—Oedema—Betamethasone—multiple sclerosis	0.000281	0.000999	CcSEcCtD
Gadoxetate—Oedema—Dexamethasone—multiple sclerosis	0.000281	0.000999	CcSEcCtD
Gadoxetate—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000281	0.000999	CcSEcCtD
Gadoxetate—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000281	0.000999	CcSEcCtD
Gadoxetate—Infection—Dexamethasone—multiple sclerosis	0.000279	0.000993	CcSEcCtD
Gadoxetate—Infection—Betamethasone—multiple sclerosis	0.000279	0.000993	CcSEcCtD
Gadoxetate—Ill-defined disorder—Prednisone—multiple sclerosis	0.000278	0.000989	CcSEcCtD
Gadoxetate—Paraesthesia—Triamcinolone—multiple sclerosis	0.000278	0.000989	CcSEcCtD
Gadoxetate—Feeling abnormal—Prednisolone—multiple sclerosis	0.000277	0.000987	CcSEcCtD
Gadoxetate—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000277	0.000987	CcSEcCtD
Gadoxetate—Shock—Betamethasone—multiple sclerosis	0.000276	0.000983	CcSEcCtD
Gadoxetate—Shock—Dexamethasone—multiple sclerosis	0.000276	0.000983	CcSEcCtD
Gadoxetate—Dyspnoea—Triamcinolone—multiple sclerosis	0.000276	0.000982	CcSEcCtD
Gadoxetate—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000275	0.00098	CcSEcCtD
Gadoxetate—Nervous system disorder—Betamethasone—multiple sclerosis	0.000275	0.00098	CcSEcCtD
Gadoxetate—Agitation—Prednisone—multiple sclerosis	0.000275	0.00098	CcSEcCtD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000275	0.00822	CbGpPWpGaD
Gadoxetate—Tachycardia—Betamethasone—multiple sclerosis	0.000274	0.000975	CcSEcCtD
Gadoxetate—Tachycardia—Dexamethasone—multiple sclerosis	0.000274	0.000975	CcSEcCtD
Gadoxetate—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000271	0.000966	CcSEcCtD
Gadoxetate—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000271	0.000966	CcSEcCtD
Gadoxetate—Malaise—Prednisone—multiple sclerosis	0.00027	0.000962	CcSEcCtD
Gadoxetate—Vertigo—Prednisone—multiple sclerosis	0.000269	0.000958	CcSEcCtD
Gadoxetate—Syncope—Prednisone—multiple sclerosis	0.000269	0.000956	CcSEcCtD
Gadoxetate—Anorexia—Betamethasone—multiple sclerosis	0.000268	0.000953	CcSEcCtD
Gadoxetate—Anorexia—Dexamethasone—multiple sclerosis	0.000268	0.000953	CcSEcCtD
Gadoxetate—Urticaria—Prednisolone—multiple sclerosis	0.000267	0.000951	CcSEcCtD
Gadoxetate—Cardiac disorder—Methotrexate—multiple sclerosis	0.000267	0.00095	CcSEcCtD
Gadoxetate—Fatigue—Triamcinolone—multiple sclerosis	0.000267	0.000949	CcSEcCtD
Gadoxetate—Fatigue—Methylprednisolone—multiple sclerosis	0.000266	0.000947	CcSEcCtD
Gadoxetate—Loss of consciousness—Prednisone—multiple sclerosis	0.000263	0.000937	CcSEcCtD
Gadoxetate—Hypotension—Dexamethasone—multiple sclerosis	0.000262	0.000934	CcSEcCtD
Gadoxetate—Hypotension—Betamethasone—multiple sclerosis	0.000262	0.000934	CcSEcCtD
Gadoxetate—Angiopathy—Methotrexate—multiple sclerosis	0.000261	0.000929	CcSEcCtD
Gadoxetate—Vomiting—Mitoxantrone—multiple sclerosis	0.000261	0.000928	CcSEcCtD
Gadoxetate—Immune system disorder—Methotrexate—multiple sclerosis	0.00026	0.000925	CcSEcCtD
Gadoxetate—Convulsion—Prednisone—multiple sclerosis	0.00026	0.000924	CcSEcCtD
Gadoxetate—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000259	0.000923	CcSEcCtD
Gadoxetate—Rash—Mitoxantrone—multiple sclerosis	0.000259	0.00092	CcSEcCtD
Gadoxetate—Dermatitis—Mitoxantrone—multiple sclerosis	0.000258	0.00092	CcSEcCtD
Gadoxetate—Chills—Methotrexate—multiple sclerosis	0.000258	0.000919	CcSEcCtD
Gadoxetate—Headache—Mitoxantrone—multiple sclerosis	0.000257	0.000914	CcSEcCtD
Gadoxetate—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000255	0.000908	CcSEcCtD
Gadoxetate—SLCO1B1—Bile acid and bile salt metabolism—ALB—multiple sclerosis	0.000255	0.00763	CbGpPWpGaD
Gadoxetate—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000254	0.000906	CcSEcCtD
Gadoxetate—Anxiety—Prednisone—multiple sclerosis	0.000254	0.000905	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000253	0.000902	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000252	0.000899	CcSEcCtD
Gadoxetate—Paraesthesia—Dexamethasone—multiple sclerosis	0.000252	0.000897	CcSEcCtD
Gadoxetate—Paraesthesia—Betamethasone—multiple sclerosis	0.000252	0.000897	CcSEcCtD
Gadoxetate—Discomfort—Prednisone—multiple sclerosis	0.000252	0.000897	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—CD58—multiple sclerosis	0.00025	0.00748	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—SELPLG—multiple sclerosis	0.00025	0.00748	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—MERTK—multiple sclerosis	0.00025	0.00748	CbGpPWpGaD
Gadoxetate—Hypersensitivity—Prednisolone—multiple sclerosis	0.000248	0.000882	CcSEcCtD
Gadoxetate—Urticaria—Triamcinolone—multiple sclerosis	0.000246	0.000875	CcSEcCtD
Gadoxetate—Urticaria—Methylprednisolone—multiple sclerosis	0.000245	0.000873	CcSEcCtD
Gadoxetate—Dysgeusia—Methotrexate—multiple sclerosis	0.000245	0.000873	CcSEcCtD
Gadoxetate—Body temperature increased—Triamcinolone—multiple sclerosis	0.000245	0.000871	CcSEcCtD
Gadoxetate—Anaphylactic shock—Prednisone—multiple sclerosis	0.000244	0.00087	CcSEcCtD
Gadoxetate—Oedema—Prednisone—multiple sclerosis	0.000244	0.00087	CcSEcCtD
Gadoxetate—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000244	0.000869	CcSEcCtD
Gadoxetate—Decreased appetite—Betamethasone—multiple sclerosis	0.000244	0.000869	CcSEcCtD
Gadoxetate—Decreased appetite—Dexamethasone—multiple sclerosis	0.000244	0.000869	CcSEcCtD
Gadoxetate—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—multiple sclerosis	0.000244	0.0073	CbGpPWpGaD
Gadoxetate—Nausea—Mitoxantrone—multiple sclerosis	0.000244	0.000867	CcSEcCtD
Gadoxetate—Infection—Prednisone—multiple sclerosis	0.000243	0.000865	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000242	0.000863	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000242	0.000863	CcSEcCtD
Gadoxetate—Back pain—Methotrexate—multiple sclerosis	0.000242	0.000862	CcSEcCtD
Gadoxetate—Fatigue—Betamethasone—multiple sclerosis	0.000242	0.000862	CcSEcCtD
Gadoxetate—Fatigue—Dexamethasone—multiple sclerosis	0.000242	0.000862	CcSEcCtD
Gadoxetate—Shock—Prednisone—multiple sclerosis	0.000241	0.000856	CcSEcCtD
Gadoxetate—Nervous system disorder—Prednisone—multiple sclerosis	0.00024	0.000853	CcSEcCtD
Gadoxetate—Tachycardia—Prednisone—multiple sclerosis	0.000239	0.000849	CcSEcCtD
Gadoxetate—Skin disorder—Prednisone—multiple sclerosis	0.000237	0.000845	CcSEcCtD
Gadoxetate—Hyperhidrosis—Prednisone—multiple sclerosis	0.000236	0.000841	CcSEcCtD
Gadoxetate—Vision blurred—Methotrexate—multiple sclerosis	0.000236	0.00084	CcSEcCtD
Gadoxetate—Anorexia—Prednisone—multiple sclerosis	0.000233	0.00083	CcSEcCtD
Gadoxetate—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000232	0.000827	CcSEcCtD
Gadoxetate—Feeling abnormal—Betamethasone—multiple sclerosis	0.000231	0.000823	CcSEcCtD
Gadoxetate—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000231	0.000823	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00023	0.000817	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00023	0.000817	CcSEcCtD
Gadoxetate—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000228	0.000811	CcSEcCtD
Gadoxetate—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000227	0.00081	CcSEcCtD
Gadoxetate—Malaise—Methotrexate—multiple sclerosis	0.000226	0.000804	CcSEcCtD
Gadoxetate—Vertigo—Methotrexate—multiple sclerosis	0.000225	0.000801	CcSEcCtD
Gadoxetate—Urticaria—Betamethasone—multiple sclerosis	0.000223	0.000794	CcSEcCtD
Gadoxetate—Urticaria—Dexamethasone—multiple sclerosis	0.000223	0.000794	CcSEcCtD
Gadoxetate—Dizziness—Prednisolone—multiple sclerosis	0.000222	0.000792	CcSEcCtD
Gadoxetate—Asthenia—Triamcinolone—multiple sclerosis	0.000222	0.00079	CcSEcCtD
Gadoxetate—Body temperature increased—Betamethasone—multiple sclerosis	0.000222	0.00079	CcSEcCtD
Gadoxetate—Abdominal pain—Dexamethasone—multiple sclerosis	0.000222	0.00079	CcSEcCtD
Gadoxetate—Abdominal pain—Betamethasone—multiple sclerosis	0.000222	0.00079	CcSEcCtD
Gadoxetate—Body temperature increased—Dexamethasone—multiple sclerosis	0.000222	0.00079	CcSEcCtD
Gadoxetate—Asthenia—Methylprednisolone—multiple sclerosis	0.000222	0.000788	CcSEcCtD
Gadoxetate—Paraesthesia—Prednisone—multiple sclerosis	0.00022	0.000781	CcSEcCtD
Gadoxetate—Pruritus—Triamcinolone—multiple sclerosis	0.000219	0.000779	CcSEcCtD
Gadoxetate—Cough—Methotrexate—multiple sclerosis	0.000218	0.000778	CcSEcCtD
Gadoxetate—Pruritus—Methylprednisolone—multiple sclerosis	0.000218	0.000777	CcSEcCtD
Gadoxetate—Convulsion—Methotrexate—multiple sclerosis	0.000217	0.000772	CcSEcCtD
Gadoxetate—SLCO1B3—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000217	0.00648	CbGpPWpGaD
Gadoxetate—Chest pain—Methotrexate—multiple sclerosis	0.000213	0.000759	CcSEcCtD
Gadoxetate—Decreased appetite—Prednisone—multiple sclerosis	0.000213	0.000756	CcSEcCtD
Gadoxetate—Rash—Prednisolone—multiple sclerosis	0.000212	0.000755	CcSEcCtD
Gadoxetate—Dermatitis—Prednisolone—multiple sclerosis	0.000212	0.000754	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000212	0.000753	CcSEcCtD
Gadoxetate—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000211	0.000752	CcSEcCtD
Gadoxetate—Fatigue—Prednisone—multiple sclerosis	0.000211	0.00075	CcSEcCtD
Gadoxetate—Headache—Prednisolone—multiple sclerosis	0.000211	0.00075	CcSEcCtD
Gadoxetate—Discomfort—Methotrexate—multiple sclerosis	0.000211	0.00075	CcSEcCtD
Gadoxetate—Constipation—Prednisone—multiple sclerosis	0.000209	0.000744	CcSEcCtD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000208	0.00623	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000208	0.00622	CbGpPWpGaD
Gadoxetate—Dizziness—Triamcinolone—multiple sclerosis	0.000205	0.000728	CcSEcCtD
Gadoxetate—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000204	0.000727	CcSEcCtD
Gadoxetate—Dizziness—Methylprednisolone—multiple sclerosis	0.000204	0.000727	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000203	0.00608	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000203	0.00608	CbGpPWpGaD
Gadoxetate—Infection—Methotrexate—multiple sclerosis	0.000203	0.000723	CcSEcCtD
Gadoxetate—Feeling abnormal—Prednisone—multiple sclerosis	0.000201	0.000717	CcSEcCtD
Gadoxetate—Asthenia—Dexamethasone—multiple sclerosis	0.000201	0.000717	CcSEcCtD
Gadoxetate—Asthenia—Betamethasone—multiple sclerosis	0.000201	0.000717	CcSEcCtD
Gadoxetate—Nervous system disorder—Methotrexate—multiple sclerosis	0.0002	0.000713	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Prednisone—multiple sclerosis	0.0002	0.000712	CcSEcCtD
Gadoxetate—Nausea—Prednisolone—multiple sclerosis	0.0002	0.000711	CcSEcCtD
Gadoxetate—Pruritus—Betamethasone—multiple sclerosis	0.000199	0.000707	CcSEcCtD
Gadoxetate—Pruritus—Dexamethasone—multiple sclerosis	0.000199	0.000707	CcSEcCtD
Gadoxetate—Skin disorder—Methotrexate—multiple sclerosis	0.000198	0.000706	CcSEcCtD
Gadoxetate—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000198	0.000703	CcSEcCtD
Gadoxetate—Vomiting—Triamcinolone—multiple sclerosis	0.000197	0.0007	CcSEcCtD
Gadoxetate—Vomiting—Methylprednisolone—multiple sclerosis	0.000196	0.000699	CcSEcCtD
Gadoxetate—Rash—Triamcinolone—multiple sclerosis	0.000195	0.000694	CcSEcCtD
Gadoxetate—Dermatitis—Triamcinolone—multiple sclerosis	0.000195	0.000694	CcSEcCtD
Gadoxetate—Anorexia—Methotrexate—multiple sclerosis	0.000195	0.000693	CcSEcCtD
Gadoxetate—Rash—Methylprednisolone—multiple sclerosis	0.000195	0.000693	CcSEcCtD
Gadoxetate—Dermatitis—Methylprednisolone—multiple sclerosis	0.000194	0.000692	CcSEcCtD
Gadoxetate—Urticaria—Prednisone—multiple sclerosis	0.000194	0.000691	CcSEcCtD
Gadoxetate—Headache—Triamcinolone—multiple sclerosis	0.000194	0.00069	CcSEcCtD
Gadoxetate—Headache—Methylprednisolone—multiple sclerosis	0.000193	0.000688	CcSEcCtD
Gadoxetate—Abdominal pain—Prednisone—multiple sclerosis	0.000193	0.000688	CcSEcCtD
Gadoxetate—Body temperature increased—Prednisone—multiple sclerosis	0.000193	0.000688	CcSEcCtD
Gadoxetate—Diarrhoea—Betamethasone—multiple sclerosis	0.000192	0.000684	CcSEcCtD
Gadoxetate—Diarrhoea—Dexamethasone—multiple sclerosis	0.000192	0.000684	CcSEcCtD
Gadoxetate—Hypotension—Methotrexate—multiple sclerosis	0.000191	0.00068	CcSEcCtD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000187	0.00561	CbGpPWpGaD
Gadoxetate—Dizziness—Dexamethasone—multiple sclerosis	0.000186	0.000661	CcSEcCtD
Gadoxetate—Dizziness—Betamethasone—multiple sclerosis	0.000186	0.000661	CcSEcCtD
Gadoxetate—Nausea—Triamcinolone—multiple sclerosis	0.000184	0.000654	CcSEcCtD
Gadoxetate—Paraesthesia—Methotrexate—multiple sclerosis	0.000183	0.000653	CcSEcCtD
Gadoxetate—Nausea—Methylprednisolone—multiple sclerosis	0.000183	0.000653	CcSEcCtD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000183	0.00549	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000183	0.00549	CbGpPWpGaD
Gadoxetate—Dyspnoea—Methotrexate—multiple sclerosis	0.000182	0.000648	CcSEcCtD
Gadoxetate—Hypersensitivity—Prednisone—multiple sclerosis	0.00018	0.000641	CcSEcCtD
Gadoxetate—Vomiting—Dexamethasone—multiple sclerosis	0.000179	0.000635	CcSEcCtD
Gadoxetate—Vomiting—Betamethasone—multiple sclerosis	0.000179	0.000635	CcSEcCtD
Gadoxetate—Decreased appetite—Methotrexate—multiple sclerosis	0.000178	0.000632	CcSEcCtD
Gadoxetate—Rash—Dexamethasone—multiple sclerosis	0.000177	0.00063	CcSEcCtD
Gadoxetate—Rash—Betamethasone—multiple sclerosis	0.000177	0.00063	CcSEcCtD
Gadoxetate—Dermatitis—Dexamethasone—multiple sclerosis	0.000177	0.000629	CcSEcCtD
Gadoxetate—Dermatitis—Betamethasone—multiple sclerosis	0.000177	0.000629	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000176	0.000628	CcSEcCtD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000176	0.00528	CbGpPWpGaD
Gadoxetate—Fatigue—Methotrexate—multiple sclerosis	0.000176	0.000627	CcSEcCtD
Gadoxetate—Headache—Betamethasone—multiple sclerosis	0.000176	0.000626	CcSEcCtD
Gadoxetate—Headache—Dexamethasone—multiple sclerosis	0.000176	0.000626	CcSEcCtD
Gadoxetate—Asthenia—Prednisone—multiple sclerosis	0.000175	0.000624	CcSEcCtD
Gadoxetate—Pruritus—Prednisone—multiple sclerosis	0.000173	0.000616	CcSEcCtD
Gadoxetate—ABCC4—Platelet degranulation—ALB—multiple sclerosis	0.00017	0.00508	CbGpPWpGaD
Gadoxetate—Feeling abnormal—Methotrexate—multiple sclerosis	0.000168	0.000599	CcSEcCtD
Gadoxetate—Diarrhoea—Prednisone—multiple sclerosis	0.000167	0.000595	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000167	0.000595	CcSEcCtD
Gadoxetate—Nausea—Dexamethasone—multiple sclerosis	0.000167	0.000594	CcSEcCtD
Gadoxetate—Nausea—Betamethasone—multiple sclerosis	0.000167	0.000594	CcSEcCtD
Gadoxetate—Urticaria—Methotrexate—multiple sclerosis	0.000162	0.000578	CcSEcCtD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—multiple sclerosis	0.000162	0.00484	CbGpPWpGaD
Gadoxetate—Dizziness—Prednisone—multiple sclerosis	0.000162	0.000575	CcSEcCtD
Gadoxetate—Abdominal pain—Methotrexate—multiple sclerosis	0.000162	0.000575	CcSEcCtD
Gadoxetate—Body temperature increased—Methotrexate—multiple sclerosis	0.000162	0.000575	CcSEcCtD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000157	0.00471	CbGpPWpGaD
Gadoxetate—Vomiting—Prednisone—multiple sclerosis	0.000155	0.000553	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—PLEK—multiple sclerosis	0.000154	0.00462	CbGpPWpGaD
Gadoxetate—Rash—Prednisone—multiple sclerosis	0.000154	0.000549	CcSEcCtD
Gadoxetate—Dermatitis—Prednisone—multiple sclerosis	0.000154	0.000548	CcSEcCtD
Gadoxetate—Headache—Prednisone—multiple sclerosis	0.000153	0.000545	CcSEcCtD
Gadoxetate—Hypersensitivity—Methotrexate—multiple sclerosis	0.000151	0.000536	CcSEcCtD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000149	0.00445	CbGpPWpGaD
Gadoxetate—Asthenia—Methotrexate—multiple sclerosis	0.000147	0.000522	CcSEcCtD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000145	0.00436	CbGpPWpGaD
Gadoxetate—Nausea—Prednisone—multiple sclerosis	0.000145	0.000517	CcSEcCtD
Gadoxetate—Pruritus—Methotrexate—multiple sclerosis	0.000145	0.000515	CcSEcCtD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000142	0.00425	CbGpPWpGaD
Gadoxetate—Diarrhoea—Methotrexate—multiple sclerosis	0.00014	0.000498	CcSEcCtD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.00014	0.00418	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000137	0.00409	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000137	0.00409	CbGpPWpGaD
Gadoxetate—Dizziness—Methotrexate—multiple sclerosis	0.000135	0.000481	CcSEcCtD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000134	0.004	CbGpPWpGaD
Gadoxetate—Vomiting—Methotrexate—multiple sclerosis	0.00013	0.000462	CcSEcCtD
Gadoxetate—Rash—Methotrexate—multiple sclerosis	0.000129	0.000459	CcSEcCtD
Gadoxetate—Dermatitis—Methotrexate—multiple sclerosis	0.000129	0.000458	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism—SRM—multiple sclerosis	0.000128	0.00384	CbGpPWpGaD
Gadoxetate—Headache—Methotrexate—multiple sclerosis	0.000128	0.000456	CcSEcCtD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000124	0.00373	CbGpPWpGaD
Gadoxetate—Nausea—Methotrexate—multiple sclerosis	0.000121	0.000432	CcSEcCtD
Gadoxetate—ABCC4—Ectoderm Differentiation—CCL2—multiple sclerosis	0.000118	0.00353	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—SRM—multiple sclerosis	0.000116	0.00347	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000113	0.00337	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000112	0.00336	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.00011	0.00329	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—SELE—multiple sclerosis	0.000109	0.00325	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—TGFB1—multiple sclerosis	0.000107	0.00322	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000106	0.00317	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000106	0.00316	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	0.000104	0.00312	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	0.000102	0.00306	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	9.93e-05	0.00297	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	9.34e-05	0.00279	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP27B1—multiple sclerosis	9.05e-05	0.00271	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP24A1—multiple sclerosis	9.05e-05	0.00271	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.91e-05	0.00267	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	8.84e-05	0.00265	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SRM—multiple sclerosis	8.63e-05	0.00258	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.36e-05	0.0025	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GPC5—multiple sclerosis	8.28e-05	0.00248	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP27B1—multiple sclerosis	8.16e-05	0.00244	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP24A1—multiple sclerosis	8.16e-05	0.00244	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	7.98e-05	0.00239	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.87e-05	0.00236	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—ITGA4—multiple sclerosis	7.86e-05	0.00235	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—IFNB1—multiple sclerosis	7.8e-05	0.00234	CbGpPWpGaD
Gadoxetate—SLCO1B3—SLC-mediated transmembrane transport—ALB—multiple sclerosis	7.8e-05	0.00233	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	7.53e-05	0.00225	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GPC5—multiple sclerosis	7.47e-05	0.00224	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.39e-05	0.00221	CbGpPWpGaD
Gadoxetate—ABCC3—NRF2 pathway—TGFB1—multiple sclerosis	7.06e-05	0.00211	CbGpPWpGaD
Gadoxetate—ABCC4—Ectoderm Differentiation—MYC—multiple sclerosis	6.96e-05	0.00208	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—RRM1—multiple sclerosis	6.86e-05	0.00205	CbGpPWpGaD
Gadoxetate—ABCC4—NRF2 pathway—TGFB1—multiple sclerosis	6.64e-05	0.00199	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—RRM1—multiple sclerosis	6.19e-05	0.00185	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	6.11e-05	0.00183	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP27B1—multiple sclerosis	6.08e-05	0.00182	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP24A1—multiple sclerosis	6.08e-05	0.00182	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.94e-05	0.00178	CbGpPWpGaD
Gadoxetate—ABCC2—NRF2 pathway—TGFB1—multiple sclerosis	5.6e-05	0.00168	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GPC5—multiple sclerosis	5.56e-05	0.00166	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—IL2RA—multiple sclerosis	5.37e-05	0.00161	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.32e-05	0.00159	CbGpPWpGaD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	5.24e-05	0.00157	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.8e-05	0.00144	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	4.76e-05	0.00143	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	4.67e-05	0.0014	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—RRM1—multiple sclerosis	4.61e-05	0.00138	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.57e-05	0.00137	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.17e-05	0.00125	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.12e-05	0.00123	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.96e-05	0.00119	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—BCHE—multiple sclerosis	3.94e-05	0.00118	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—ALB—multiple sclerosis	3.88e-05	0.00116	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.76e-05	0.00113	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.57e-05	0.00107	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.57e-05	0.00107	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—BCHE—multiple sclerosis	3.55e-05	0.00106	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.36e-05	0.00101	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—IL2—multiple sclerosis	3.15e-05	0.000942	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.07e-05	0.000919	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.83e-05	0.000848	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.8e-05	0.000838	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.66e-05	0.000797	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—BCHE—multiple sclerosis	2.65e-05	0.000792	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—TGFB1—multiple sclerosis	2.46e-05	0.000735	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—MAPK1—multiple sclerosis	2.41e-05	0.000721	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—APOE—multiple sclerosis	2.37e-05	0.000709	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—APOE—multiple sclerosis	2.14e-05	0.00064	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—POMC—multiple sclerosis	2.04e-05	0.000609	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ALB—multiple sclerosis	1.86e-05	0.000555	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—POMC—multiple sclerosis	1.84e-05	0.00055	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ALB—multiple sclerosis	1.67e-05	0.000501	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—APOE—multiple sclerosis	1.59e-05	0.000476	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—POMC—multiple sclerosis	1.37e-05	0.000409	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ALB—multiple sclerosis	1.25e-05	0.000373	CbGpPWpGaD
